Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 tirzepatide study (Japan)
jRCT2080224840Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 3 trial of tirzepatide, sponsored by Eli Lilly and Company. Started Aug 2019; status: completed.
02
Drugs
Beyond the preview
Go deeper on jRCT2080224840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224840.